Table 2.
Common Necroinflammatory and Cholestatic Injury Patterns
| Pattern | Characteristic features | Non-DILI differential | ALT/ULN1 | AP/ULN1 | Frequency2 |
|---|---|---|---|---|---|
| Acute (Lobular) Hepatitis | Lobular-dominant inflammation with/without confluent or bridging necrosis; no cholestasis | Acute viral hepatitis, acute autoimmune hepatitis | 13 to 27 | 1 to 3 | 21% |
| Chronic (Portal) Hepatitis | Portal-dominant inflammation, interface hepatitis (also includes mononucleosis pattern), with or without portal-based fibrosis; no cholestasis | Chronic viral or autoimmune diseases, early PBC/PSC, mononucleosis-associated hepatitis, reactive hepatitis from systemic disease, common variable immunodeficency | 3 to 10 | 1 to 2 | 14% |
| Zonal Coagulative Necrosis | Zone 3 or 1 coagulative necrosis, usually without significant inflammation | Hypoxic-ischemic injury (zone 3) | 6 to 47 | 1 to 2 | 3% |
| Cholestatic Hepatitis | Acute or chronic hepatitis pattern plus zone 3 cholestasis | Acute viral hepatitis, large duct obstruction, graft-vs-host disease | 2 to 13 | 1 to 3 | 29% |
| Acute Cholestasis (Intrahepatic, Canalicular) | Hepatocellular and/or canalicular cholestasis in zone 3; may show duct injury, but little inflammation | Sepsis, acute large duct obstruction, benign recurrent intrahepatic cholestasis | 2 to 10 | 1 to 4 | 9% |
| Chronic Cholestasis | Periportal cholate stasis, periportal fibrosis, copper accumulation, duct sclerosis or injury, duct loss | PSC, PBC, chronic cholestatic injury/AIH overlap, chronic large duct obstruction, idiopathic adulthood ductopenia, ductopenic GVHD, IgG4 related systemic sclerosis | 3 to 12 | 2 to 8 | 10% |